Precision Wealth Strategies, LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1844197 SAINT LOUIS, MO

Position in HALO

as of Mar 31, 2026 · filed May 6, 2026 Compact

Position Value

$467,533

+$7,403 QoQ

Shares Held

7,234

+5.8% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.30%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Precision Wealth Strategies, LLC holds $2,065,005 across 3 Biotechnology names. HALO ranks #3 (22.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TBPH	Theravance Biopharma, Inc.	62,815	$1,019,487
2	EXEL	Exelixis, Inc.	13,476	$577,985
3	HALO	Halozyme Therapeutics, Inc. This page	7,234	$467,533

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$467,533	7,234	+5.8%	Shares	Sole	2026-05-06
2025-12-31	$460,130	6,837	-34.6%	Shares	Sole	2026-01-30
2025-09-30	$766,989	10,458	—	Shares	Sole	2025-10-16
No filing history on record for this holder in this stock.